Invesco
SLDB icon

Invesco’s Solid Biosciences SLDB Stock Holding History

Invesco’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.43M Sell
143,437
-197,503
-58% -$1.5M ﹤0.01% 2738
2026
Q1 		$2.45M Buy
340,940
+188,814
+124% +$1.21M ﹤0.01% 2452
2025
Q4 		$858K Buy
152,126
+34,758
+30% +$188K ﹤0.01% 2975
2025
Q3 		$724K Buy
117,368
+37,000
+46% +$216K ﹤0.01% 3079
2025
Q2 		$391K Buy
80,368
+40,188
+100% +$142K ﹤0.01% 3270
2025
Q1 		$149K Buy
40,180
+27,943
+228% +$120K ﹤0.01% 3574
2024
Q4 		$48.9K Buy
+12,237
New +$67.2K ﹤0.01% 3691
2024
Q3 		– Sell
-10,258
Closed -$58.2K – 3871
2024
Q2 		$58.2K Sell
10,258
-461,849
-98% -$4.14M ﹤0.01% 3805
2024
Q1 		$6.29M Buy
+472,107
New +$4.42M ﹤0.01% 2081
2022
Q2 		– Sell
-1,268
Closed -$23K – 4130
2022
Q1 		$23K Buy
1,268
+26
+2% +$459 ﹤0.01% 3983
2021
Q4 		$32K Sell
1,242
-307
-20% -$9.38K ﹤0.01% 4009
2021
Q3 		$56K Buy
1,549
+212
+16% +$9K ﹤0.01% 3998
2021
Q2 		$73K Buy
+1,337
New +$88.3K ﹤0.01% 3928
2019
Q4 		– Sell
-5,379
Closed -$834K – 3693
2019
Q3 		$834K Buy
+5,379
New +$609K ﹤0.01% 3070

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco's SLDB Position: Q2 2026 in Review

Invesco reduced its Solid Biosciences (SLDB) stake by 58% in Q2 2026, selling an estimated $1.5M and leaving 143,437 shares worth $1.43M. The position accounts for ﹤0.01% of the portfolio, ranked #2738.

Invesco first reported a position in SLDB in Q3 2019 and has held it in 14 quarters since. The position peaked at $6.29M in Q1 2024. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Invesco held 143,437 shares of Solid Biosciences worth $1.43M as of Q2 2026.
  • Invesco sold 197,503 Solid Biosciences shares in Q2 2026, an estimated $1.5M.
  • Solid Biosciences made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #2738 holding.
  • Invesco first reported a position in Solid Biosciences in Q3 2019 and has held it in 14 quarters since.
  • Invesco's Solid Biosciences position peaked at $6.29M in Q1 2024.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.